FN1 and cancer: The mechanisms through which the VEGFR1+ cells respond to fibronectin within the pre-metastatic niche remain unclear and much of this work is based on observation rather than mechanistic evaluation, but it nonetheless, it highlights the potential relevance of targeting ECM glycoproteins in order to affect cancer immunity.